These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37046049)

  • 1. The impact of mesorectal fat area on recurrence following total mesorectal excision for lower rectal cancer.
    Shioi I; Yamaoka Y; Shiomi A; Kagawa H; Hino H; Manabe S; Chen K; Nanishi K; Notsu A
    Langenbecks Arch Surg; 2023 Apr; 408(1):147. PubMed ID: 37046049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesorectal fat area as a useful predictor of the difficulty of robotic-assisted laparoscopic total mesorectal excision for rectal cancer.
    Yamaoka Y; Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Furutani A; Manabe S; Torii K; Koido K; Mori K
    Surg Endosc; 2019 Feb; 33(2):557-566. PubMed ID: 30006838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the mesorectal fat area impact the histopathology metrics of the specimen in males undergoing TME for distal rectal cancer?
    Felsenreich DM; Gachabayov M; Bergamaschi R;
    Updates Surg; 2023 Apr; 75(3):581-588. PubMed ID: 36513913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of mesorectal fat: new prognostic biomarker in patients with mid-to-lower rectal cancer.
    Yoon J; Chung YE; Lim JS; Kim MJ
    Eur Radiol; 2019 Mar; 29(3):1240-1247. PubMed ID: 30229270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.
    Liu J; Yu X; Huang X; Lai Q; Chen J
    Cancer Imaging; 2023 Jan; 23(1):5. PubMed ID: 36635737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R; Cong L; Qiu HZ; Lin GL; Wu B; Niu BZ; Sun XY; Zhou JL; Xu L; Lu JY; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):522-530. PubMed ID: 35754217
    [No Abstract]   [Full Text] [Related]  

  • 7. Total mesorectal excision quality in rectal cancer surgery affects local recurrence rate but not distant recurrence and survival: population-based cohort study.
    Collin Å; Dahlbäck C; Folkesson J; Buchwald P
    BJS Open; 2024 Jul; 8(4):. PubMed ID: 39113260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer.
    Veltcamp Helbach M; Koedam TWA; Knol JJ; Diederik A; Spaargaren GJ; Bonjer HJ; Tuynman JB; Sietses C
    Surg Endosc; 2019 Jan; 33(1):94-102. PubMed ID: 29967990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesorectal fat area and mesorectal area affect the surgical difficulty of robotic-assisted mesorectal excision and intersphincteric resection respectively in different ways.
    Huang S; Chen M; Deng Y; Wang X; Lu X; Jiang W; Huang Y; Chi P
    Colorectal Dis; 2020 Sep; 22(9):1130-1138. PubMed ID: 32040248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
    Law WL; Chu KW
    Ann Surg; 2004 Aug; 240(2):260-8. PubMed ID: 15273550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
    Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
    Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robotic Resection is a Good Prognostic Factor in Rectal Cancer Compared with Laparoscopic Resection: Long-term Survival Analysis Using Propensity Score Matching.
    Kim J; Baek SJ; Kang DW; Roh YE; Lee JW; Kwak HD; Kwak JM; Kim SH
    Dis Colon Rectum; 2017 Mar; 60(3):266-273. PubMed ID: 28177988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of robotic total mesorectal excision on survival of patients with rectal cancer-a propensity matched analysis.
    Tejedor P; Sagias F; Flashman K; Lee YH; Naqvi S; Kandala N; Khan J
    Int J Colorectal Dis; 2019 Dec; 34(12):2081-2089. PubMed ID: 31712874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial.
    Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
    JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term oncological outcomes in robotic versus laparoscopic approach for rectal cancer: A systematic review and meta-analysis.
    Qiu H; Yu D; Ye S; Shan R; Ai J; Shi J
    Int J Surg; 2020 Aug; 80():225-230. PubMed ID: 32251720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy.
    Lim DR; Bae SU; Hur H; Min BS; Baik SH; Lee KY; Kim NK
    Surg Endosc; 2017 Apr; 31(4):1728-1737. PubMed ID: 27631313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery.
    Feroci F; Vannucchi A; Bianchi PP; Cantafio S; Garzi A; Formisano G; Scatizzi M
    World J Gastroenterol; 2016 Apr; 22(13):3602-10. PubMed ID: 27053852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local recurrence in patients treated for rectal cancer using total mesorectal excision or transection of mesorectum.
    Vojnosanit Pregl; 2016 Oct; 73(10):927-33. PubMed ID: 29327910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of transanal total mesorectal excision and robotic total mesorectal excision for low rectal cancer after neoadjuvant chemoradiotherapy.
    Shin JK; Kim HC; Yun SH; Park YA; Cho YB; Huh JW; Lee WY
    Surg Endosc; 2021 Dec; 35(12):6998-7004. PubMed ID: 33523275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.